AMPHASTAR PHARMACEUTICALS IN (AMPH) Stock Fundamental Analysis
NASDAQ:AMPH - Nasdaq - US03209R1032 - Common Stock - Currency: USD
Taking everything into account, AMPH scores 6 out of 10 in our fundamental rating. AMPH was compared to 197 industry peers in the Pharmaceuticals industry. AMPH scores excellent on profitability, but there are some minor concerns on its financial health. AMPH scores decently on growth, while it is valued quite cheap. This could make an interesting combination. This makes AMPH very considerable for value investing!
1. Profitability
1.1 Basic Checks
In the past year AMPH was profitable.
In the past year AMPH had a positive cash flow from operations.
Each year in the past 5 years AMPH has been profitable.
Each year in the past 5 years AMPH had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 10.11%, AMPH belongs to the best of the industry, outperforming 93.91% of the companies in the same industry.
With an excellent Return On Equity value of 21.78%, AMPH belongs to the best of the industry, outperforming 93.91% of the companies in the same industry.
The Return On Invested Capital of AMPH (12.13%) is better than 88.83% of its industry peers.
AMPH had an Average Return On Invested Capital over the past 3 years of 12.92%. This is significantly below the industry average of 40.40%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.11% | ||
| ROE | 21.78% | ||
| ROIC | 12.13% |
ROA(3y)10.51%
ROA(5y)8.2%
ROE(3y)20.19%
ROE(5y)14.97%
ROIC(3y)12.92%
ROIC(5y)10.14%
1.3 Margins
AMPH's Profit Margin of 21.79% is amongst the best of the industry. AMPH outperforms 94.42% of its industry peers.
In the last couple of years the Profit Margin of AMPH has grown nicely.
AMPH's Operating Margin of 28.06% is amongst the best of the industry. AMPH outperforms 93.40% of its industry peers.
In the last couple of years the Operating Margin of AMPH has grown nicely.
Looking at the Gross Margin, with a value of 51.08%, AMPH is in the better half of the industry, outperforming 62.94% of the companies in the same industry.
In the last couple of years the Gross Margin of AMPH has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 28.06% | ||
| PM (TTM) | 21.79% | ||
| GM | 51.08% |
OM growth 3Y20.68%
OM growth 5YN/A
PM growth 3Y15.39%
PM growth 5Y7.52%
GM growth 3Y3.84%
GM growth 5Y4.54%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AMPH is still creating some value.
AMPH has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, AMPH has more shares outstanding
AMPH has a better debt/assets ratio than last year.
2.2 Solvency
AMPH has an Altman-Z score of 2.46. This is not the best score and indicates that AMPH is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of AMPH (2.46) is better than 74.62% of its industry peers.
AMPH has a debt to FCF ratio of 3.49. This is a good value and a sign of high solvency as AMPH would need 3.49 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 3.49, AMPH belongs to the best of the industry, outperforming 89.34% of the companies in the same industry.
A Debt/Equity ratio of 0.82 indicates that AMPH is somewhat dependend on debt financing.
The Debt to Equity ratio of AMPH (0.82) is worse than 70.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | 3.49 | ||
| Altman-Z | 2.46 |
ROIC/WACC1.33
WACC9.15%
2.3 Liquidity
A Current Ratio of 3.07 indicates that AMPH has no problem at all paying its short term obligations.
AMPH has a Current ratio of 3.07. This is comparable to the rest of the industry: AMPH outperforms 53.81% of its industry peers.
AMPH has a Quick Ratio of 2.19. This indicates that AMPH is financially healthy and has no problem in meeting its short term obligations.
AMPH has a Quick ratio of 2.19. This is comparable to the rest of the industry: AMPH outperforms 48.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.07 | ||
| Quick Ratio | 2.19 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 16.97% over the past year.
AMPH shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 61.62% yearly.
Looking at the last year, AMPH shows a quite strong growth in Revenue. The Revenue has grown by 13.59% in the last year.
The Revenue has been growing by 17.82% on average over the past years. This is quite good.
EPS 1Y (TTM)16.97%
EPS 3Y41.58%
EPS 5Y61.62%
EPS Q2Q%4.55%
Revenue 1Y (TTM)13.59%
Revenue growth 3Y18.69%
Revenue growth 5Y17.82%
Sales Q2Q%4.73%
3.2 Future
The Earnings Per Share is expected to decrease by -0.40% on average over the next years.
Based on estimates for the next years, AMPH will show a small growth in Revenue. The Revenue will grow by 3.43% on average per year.
EPS Next Y-17.6%
EPS Next 2Y-1.34%
EPS Next 3Y1.61%
EPS Next 5Y-0.4%
Revenue Next Year-0.02%
Revenue Next 2Y3.25%
Revenue Next 3Y3.42%
Revenue Next 5Y3.43%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
AMPH is valuated cheaply with a Price/Earnings ratio of 6.05.
Based on the Price/Earnings ratio, AMPH is valued cheaper than 94.42% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.29. AMPH is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 7.34, which indicates a rather cheap valuation of AMPH.
AMPH's Price/Forward Earnings ratio is rather cheap when compared to the industry. AMPH is cheaper than 93.40% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.08. AMPH is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.05 | ||
| Fwd PE | 7.34 |
4.2 Price Multiples
AMPH's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AMPH is cheaper than 93.40% of the companies in the same industry.
AMPH's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AMPH is cheaper than 92.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.46 | ||
| EV/EBITDA | 5.42 |
4.3 Compensation for Growth
AMPH has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.1
EPS Next 2Y-1.34%
EPS Next 3Y1.61%
5. Dividend
5.1 Amount
AMPH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
23.35
+0.36 (+1.57%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners74.42%
Inst Owner Change0%
Ins Owners8.05%
Ins Owner Change1.24%
Market Cap1.11B
Analysts78.33
Price Target37.23 (59.44%)
Short Float %11.21%
Short Ratio7.07
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.65%
Min EPS beat(2)-4.74%
Max EPS beat(2)-4.55%
EPS beat(4)2
Avg EPS beat(4)4.1%
Min EPS beat(4)-4.74%
Max EPS beat(4)19.17%
EPS beat(8)5
Avg EPS beat(8)14.19%
EPS beat(12)8
Avg EPS beat(12)18.5%
EPS beat(16)11
Avg EPS beat(16)22.73%
Revenue beat(2)0
Avg Revenue beat(2)-3.29%
Min Revenue beat(2)-3.71%
Max Revenue beat(2)-2.87%
Revenue beat(4)1
Avg Revenue beat(4)-1.29%
Min Revenue beat(4)-3.71%
Max Revenue beat(4)4.61%
Revenue beat(8)4
Avg Revenue beat(8)0.25%
Revenue beat(12)7
Avg Revenue beat(12)0.48%
Revenue beat(16)10
Avg Revenue beat(16)1.29%
PT rev (1m)-17.51%
PT rev (3m)-36.8%
EPS NQ rev (1m)-3.38%
EPS NQ rev (3m)-28.03%
EPS NY rev (1m)-14.99%
EPS NY rev (3m)-26.53%
Revenue NQ rev (1m)-0.54%
Revenue NQ rev (3m)-7.5%
Revenue NY rev (1m)-0.44%
Revenue NY rev (3m)-7.99%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.05 | ||
| Fwd PE | 7.34 | ||
| P/S | 1.52 | ||
| P/FCF | 6.46 | ||
| P/OCF | 5.21 | ||
| P/B | 1.52 | ||
| P/tB | 7.86 | ||
| EV/EBITDA | 5.42 |
EPS(TTM)3.86
EY16.53%
EPS(NY)3.18
Fwd EY13.62%
FCF(TTM)3.62
FCFY15.49%
OCF(TTM)4.48
OCFY19.18%
SpS15.36
BVpS15.37
TBVpS2.97
PEG (NY)N/A
PEG (5Y)0.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.11% | ||
| ROE | 21.78% | ||
| ROCE | 14.63% | ||
| ROIC | 12.13% | ||
| ROICexc | 14.41% | ||
| ROICexgc | 28.79% | ||
| OM | 28.06% | ||
| PM (TTM) | 21.79% | ||
| GM | 51.08% | ||
| FCFM | 23.55% |
ROA(3y)10.51%
ROA(5y)8.2%
ROE(3y)20.19%
ROE(5y)14.97%
ROIC(3y)12.92%
ROIC(5y)10.14%
ROICexc(3y)16.46%
ROICexc(5y)13%
ROICexgc(3y)29.66%
ROICexgc(5y)21.24%
ROCE(3y)15.59%
ROCE(5y)12.24%
ROICexcg growth 3Y24.9%
ROICexcg growth 5YN/A
ROICexc growth 3Y2.33%
ROICexc growth 5YN/A
OM growth 3Y20.68%
OM growth 5YN/A
PM growth 3Y15.39%
PM growth 5Y7.52%
GM growth 3Y3.84%
GM growth 5Y4.54%
F-Score8
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | 3.49 | ||
| Debt/EBITDA | 2.29 | ||
| Cap/Depr | 71.74% | ||
| Cap/Sales | 5.61% | ||
| Interest Coverage | 7.66 | ||
| Cash Conversion | 81.25% | ||
| Profit Quality | 108.04% | ||
| Current Ratio | 3.07 | ||
| Quick Ratio | 2.19 | ||
| Altman-Z | 2.46 |
F-Score8
WACC9.15%
ROIC/WACC1.33
Cap/Depr(3y)86.1%
Cap/Depr(5y)106.5%
Cap/Sales(3y)5.45%
Cap/Sales(5y)6.46%
Profit Quality(3y)95%
Profit Quality(5y)414.14%
High Growth Momentum
Growth
EPS 1Y (TTM)16.97%
EPS 3Y41.58%
EPS 5Y61.62%
EPS Q2Q%4.55%
EPS Next Y-17.6%
EPS Next 2Y-1.34%
EPS Next 3Y1.61%
EPS Next 5Y-0.4%
Revenue 1Y (TTM)13.59%
Revenue growth 3Y18.69%
Revenue growth 5Y17.82%
Sales Q2Q%4.73%
Revenue Next Year-0.02%
Revenue Next 2Y3.25%
Revenue Next 3Y3.42%
Revenue Next 5Y3.43%
EBIT growth 1Y4.28%
EBIT growth 3Y43.24%
EBIT growth 5YN/A
EBIT Next Year-2.55%
EBIT Next 3Y6.97%
EBIT Next 5Y5.95%
FCF growth 1Y18.58%
FCF growth 3Y34.69%
FCF growth 5Y286.43%
OCF growth 1Y16.28%
OCF growth 3Y29.62%
OCF growth 5Y38.57%